Skip to content
Tissue and Cell Culture Reagents Online

Tissue and Cell Culture Reagents Online

Fbs, Bsa, Fetal Bovine Serum for primary cells

Menu
  • Home
  • ELISA KITS
  • ANTIBODY
  • RNA
  • DNA
  • Culture
  • Distributors
  • Contact Us
Menu
Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer.

Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer.

Posted on May 10, 2020January 19, 2022 by Jack

Molecular concentrating on is a highly effective method for aggressive claudin-low breast most cancers (CLBC). Overexpression of PI3K catalytic subunit gamma (PIK3CG) in human CLBC is providing a promising alternative for focused therapies. We utilized a particular inhibitor of PIK3CG mixed with paclitaxel (PTX) to deal with CLBC cells in vitro and in vivo.

The tumor cells progress and apoptosis in vitro had been analyzed by CCK8, plate clone formation assay, tumorsphere assay, Hoechst staining and circulation cytometry. The invasion and metastasis skill of tumor cells in vitro had been investigated by wound therapeutic and transwell experiments.

Critical gene expression ranges had been checked by qRT-PCR and Western blot. Xenograft fashions with CLBC cell traces in SCID mice had been established to analyze the impact of mixed medicine in vivo.We recognized that PIK3CG was a potential therapeutic goal for CLBC sufferers.

Targeting PIK3CG potentiated CLBC cells progress inhibition in 2D and 3D cultures by PTX. Inhibition of PIK3CG activation may improve CLBC cells apoptosis and migration suppression induced by PTX. Manipulating autophagy was a validated method for the usage of PIK3CG inhibitor.

Using CLBC xenograft mice mannequin, we discovered that CLBC tumors in vivo could possibly be nicely handled by mixed medicine of PIK3CG inhibitor and PTX.We demonstrated that PIK3CG was a potential goal for the remedy of CLBC and inhibition of PIK3CG activation may reinforce the therapeutic impact of this aggressive illness by PTX. The mixed use of PIK3CG inhibitor and PTX may be a potential routine for treating this subtype of breast most cancers.

Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer.
Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer.

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal metabolic disorder caused by thymidine phosphorylase (TP) deficiency. Successful therapeutic interventions for this disease rely on a means for efficient and long-lasting circulation of the TP enzyme.

In this study we exploit lentiviral transduction of hematopoietic stem cells and an erythroid cell line (BEL-A) to generate reticulocytes that contain active TP.

See it here: Rat N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ELISA Kit | abx054654

Significant loss of overexpressed TP during erythroid differentiation can be reduced by addition of the ubiquitination inhibitor MG132. However, the ubiquitination sites are located in the substrate binding site in human TP, and their removal abolished enzyme activity. Examination of the TP structure and mechanism suggested that these sites are only exposed in the absence of substrate.

We show that supplementation of culture media with thymidine during differentiation reduces enzyme degradation, doubling the amount of TP retained in reticulocytes. This study provides proof of principle that therapeutic reticulocytes expressing TP can be generated in vitro and that ubiquitin-mediated degradation can be subverted through masking ubiquitination sites to ensure retention of human TP in reticulocytes following erythroid differentiation.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« May    

RSS Cell Stem Cell

  • To play Paneth or goblet: Shapeshifting secretory cells read the room
  • Rapid generation of functional vascular organoids via simultaneous transcription factor activation of endothelial and mural lineages
  • An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer
  • Multiomic profiling reveals that prostaglandin E2 reverses aged muscle stem cell dysfunction, leading to increased regeneration and strength
  • Human airway submucosal gland organoids to study respiratory inflammation and infection
  • Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy
  • IGF2BP1 restricts the induction of human primordial germ cell fate in an m6A-dependent manner
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
  • Establishing dorsal-ventral patterning in human neural tube organoids with synthetic organizers
  • Integrating collecting systems in human kidney organoids through fusion of distal nephron to ureteric bud
  • ANTIBODY
  • blood
  • Camel
  • Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer.
  • coli recombinant
  • colorimetric
  • colorless
  • Containing
  • Culture
  • DNA
  • ELISA KITS
  • genome
  • GMO
  • Human Cerebrospinal Fluid Induces Neuronal Excitability Changes in Resected Human Neocortical and Hippocampal Brain Slices.
  • Quantitative Imaging of Changes in Astrocytic and Neuronal Adenosine Triphosphate Using Two Different Variants of ATeam.
  • Resolvin E1 in Follicular Fluid Acts as a Potential Biomarker and Improves Oocyte Developmental Competence by Optimizing Cumulus Cells.
  • RNA
  • Sheep
  • Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer.
  1. A WordPress Commenter on Hello world!February 28, 2020

    Hi, this is a comment. To get started with moderating, editing, and deleting comments, please visit the Comments screen in…

Recent Posts

  • Cell Culture Media Overview
  • Discover AffiMEDIUM, the New Product Line for Culture Medium
  • Capilia Rapid Antigen
  • Compare antibodies lab reagents for research
  • Compare recombinant lab reagents for research

  • ANTIBODY
  • blood
  • Camel
  • Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer.
  • coli recombinant
  • colorimetric
  • colorless
  • Containing
  • Culture
  • DNA
  • ELISA KITS
  • genome
  • GMO
  • Human Cerebrospinal Fluid Induces Neuronal Excitability Changes in Resected Human Neocortical and Hippocampal Brain Slices.
  • Quantitative Imaging of Changes in Astrocytic and Neuronal Adenosine Triphosphate Using Two Different Variants of ATeam.
  • Resolvin E1 in Follicular Fluid Acts as a Potential Biomarker and Improves Oocyte Developmental Competence by Optimizing Cumulus Cells.
  • RNA
  • Sheep
  • Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer.
  • Cell Culture Media Overview
  • Discover AffiMEDIUM, the New Product Line for Culture Medium
  • Capilia Rapid Antigen
  • Compare antibodies lab reagents for research
  • Compare recombinant lab reagents for research
© 2025 Tissue and Cell Culture Reagents Online | Powered by Superbs Personal Blog theme